Forschung

Link zu Researchgate

Forschungsinteressen
Forschung Intensivmedizin

• Frührehabilitation/mobilisation
• Langzeitoutcome von Intensivpatienten
• Ernährung des Intensivpatienten

Forschung Notfallmedizin

• Schmerztherapie
• Beatmung

Forschung Anästhesie

• Reversierung von Muskelrelaxantien
• SUPERADD-Studie

Bibliography

2019:

• Schaller SJ, Altmann S, Unsworth A, et al. Continuous chest compressions with a simultaneous triggered ventilator in the Munich Emergency Medical Services: a case series. GMS Ger Med Sci 2019; 17:Doc06 (20190626)
• Schaller SJ, Scheffenbichler FT, Bose S, et al. Influence of the initial level of consciousness on early, goal-directed mobilization: a post hoc analysis. Intensive care medicine. 2019. 
• Schaller SJ, Kappler FP, Hofberger C, et al. Differences in pain treatment between surgeons and anaesthesiologists in a physician staffed prehospital emergency medical service: a retrospective cohort analysis. BMC anesthesiology. 2019;19(1):18.  

2018:

• Kirmeier E, Abad Gurumeta A, Alfredo et al. and the Popular Contributors*. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. The Lancet Respiratory Medicine. 2018; 7(2):129 - 140 (*Schaller SJ is part of the Popular Contributors)
• Muessig JM, Nia AM, Masyuk M, Lauten A, Sacher AL, Brenner T, Franz M, Bloos F, Ebelt H, Schaller SJ, Fuest K, et al.: Clinical Frailty Scale (CFS) reliably stratifies octogenarians in German ICUs: a multicentre prospective cohort study. DOI: 10.1186/s12877-018-0847-7 BMC Geriatrics 2018; 18(1)
  
• Schaller SJ, Nagashima M, Schönfelder M, et al. GTS-21 attenuates loss of body mass, muscle mass, and function in rats having systemic inflammation with and without disuse atrophy. Pflügers Archiv - European Journal of Physiology 2018; pp. 1-11.
  
• Fuest K, Schaller SJ. Recent evidence on early mobilization in critical-Ill patients. Current opinion in anaesthesiology 2018;31:144-50.
  
• Guidet B, Flaatten H, et al for the group VIPs*: Withholding or withdrawing of life-sustaining therapy in older adults (>/= 80 years) admitted to the intensive care unit. Intensive Care Med 2018 (* Schaller SJ is part of the VIP study group)
• Schaller SJ, Nydahl P, Blobner M, Latronico N, Hodgson C. What does the EPICC trial really tell us? e-letter BMJ 2018
  

2017

• Eikermann M, Schaller SJ, Kasotakis G, Anstey M, Houle T. Early goal-directed mobilisation after surgery - Authors' reply. Lancet 2017;389:695-6.
  
• Flaatten H, De Lange DW, Morandi A, et al for the VIP1 study group*. The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (>/= 80 years). Intensive care medicine 2017;43:1820-8. (* Schaller SJ is part of the VIP study group)
  
• Schaller SJ, Alam SM, Mao J, Zhao Y, Blobner M, Greenblatt DJ, Martyn JA: Pharmacokinetics cannot explain the increased effective dose requirement for morphine and midazolam in rats during their extended administration alone or in combination. J Pharm Pharmacol 2017; 69: 82-88
  

2016

• Schaller SJ, Anstey M, Blobner M, Edrich T, Grabitz SD, Gradwohl-Matis I, Heim M, Houle T, Kurth T, Latronico N, Lee J, Meyer MJ, Peponis T, Talmor D, Velmahos GC, Waak K, Walz JM, Zafonte R, Eikermann M: Early, goal-directed mobilisation in the surgical intensive care unit: a randomised controlled trial. Lancet 2016; 388: 1377-1388
  
• Schaller SJ, Lewald H: Clinical pharmacology and efficacy of sugammadex in the reversal of neuromuscular blockade. Expert Opin Drug Metab Toxicol 2016; 12: 1097-108
  
• Schaller SJ, Stauble CG, Suemasa M, Heim M, Duarte IM, Mensch O, Bogdanski R, Lewald H, Eikermann M, Blobner M: The German Validation Study of the Surgical Intensive Care Unit Optimal Mobility Score. J Crit Care 2016; 32: 201-6
  
• Kaufhold N, Schaller SJ, Stauble CG, Baumuller E, Ulm K, Blobner M, Fink H: Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20). Br J Anaesth 2016; 116: 233-40
  

2015

• Stauble CG, Stauble RB, Schaller SJ, Unterbuchner C, Fink H, Blobner M: Effects of single-shot and steady-state propofol anaesthesia on rocuronium dose-response relationship: a randomised trial. Acta Anaesthesiol Scand 2015; 59: 902-11
  
• Nagashima M, Sasakawa T, Schaller SJ, Martyn JA: Block of postjunctional muscle-type acetylcholine receptors in vivo causes train-of-four fade in mice. Br J Anaesth 2015; 115: 122-7
  
• Baumuller E, Schaller SJ, Chiquito Lama Y, Frick CG, Bauhofer T, Eikermann M, Fink H, Blobner M: Postoperative impairment of motor function at train-of-four ratio >/=0.9 cannot be improved by sugammadex (1 mg kg-1). Br J Anaesth2015; 114: 785-93
  
• Blobner M, Frick CG, Stauble RB, Feussner H, Schaller SJ, Unterbuchner C, Lingg C, Geisler M, Fink H: Neuromuscular blockade improves surgical conditions (NISCO). Surg Endosc 2015; 29: 627-36
  

2014
Kramer C, Jordan D, Kretschmer A, Lehmeyer V, Kellermann K, Schaller SJ, Blobner M, Kochs EF, Fink H: Electromyographic permutation entropy quantifies diaphragmatic denervation and reinnervation. PLoS One2014; 9: e115754

2013

Schaller SJ, Fink H: Sugammadex as a reversal agent for neuromuscular block: an evidence-based review. Core Evid2013; 8: 57-67

2010

Schaller SJ, Fink H, Ulm K, Blobner M: Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. Anesthesiology2010; 113: 1054-60